Table 5.
Remission |
Low |
Moderate |
High |
|||||
---|---|---|---|---|---|---|---|---|
z | p-Value | z | p-Value | z | p-Value | z | p-Value | |
A. DAS28-ESR | ||||||||
PGA | 6.73 | <0.0001 | 4.49 | <0.0001 | 8.39 | <0.0001 | 5.82 | <0.0001 |
TJC28 | 6.24 | <0.0001 | 6.84 | <0.0001 | −2.61 | 0.0090 | −13.61 | <0.0001 |
SJC28 | 3.65 | 0.0003 | 1.94 | 0.0520 | −0.88 | 0.3791 | −5.32 | <0.0001 |
ESR | −14.33 | <0.0001 | −9.59 | <0.0001 | −13.41 | <0.0001 | −3.57 | 0.0004 |
DAS28-ESR | −7.34 | <0.0001 | −0.49 | 0.6245 | −7.94 | <0.0001 | −10.44 | <0.0001 |
B. CDAI | ||||||||
PGA | 1.99 | 0.0465 | −3.71 | 0.0002 | 4.64 | <0.0001 | 4.40 | <0.0001 |
MDGA | 10.63 | <0.0001 | 11.84 | <0.0001 | 10.4 | <0.0001 | 7.75 | <0.0001 |
TJC28 | 1.37 | 0.1713 | −3.38 | 0.0007 | −7.95 | <0.0001 | −11.06 | <0.0001 |
SJC28 | −4.59 | <0.0001 | −4.26 | <0.0001 | −6.11 | <0.0001 | −5.99 | <0.0001 |
CDAI | 5.87 | <0.0001 | −0.85 | 0.3949 | −2.85 | 0.0044 | −8.76 | <0.0001 |
C. SDAI | ||||||||
PGA | −3.56 | 0.0004 | −1.77 | 0.0763 | 4.52 | <0.0001 | 1.67 | 0.0955 |
MDGA | 3.66 | 0.0003 | 9.13 | <0.0001 | 13.58 | <0.0001 | 6.79 | <0.0001 |
TJC28 | 1.90 | 0.0575 | 0.06 | 0.9515 | −0.31 | 0.7548 | −2.37 | 0.0179 |
SJC28 | −1.91 | 0.0555 | −3.39 | 0.0007 | −5.78 | <0.0001 | −3.52 | 0.0004 |
CRP | −1.54 | 0.1232 | −2.4 | 0.0162 | −7.27 | <0.0001 | −1.62 | 0.1050 |
SDAI | −0.86 | 0.3912 | 1.31 | 0.19 | 1.22 | 0.2233 | −2.94 | 0.0033 |
Visits, number of visits (%); PGA, patient assessment of disease activity (100 mm); TJC28, 28 tender joint count; SJC28, 28 swollen joint count; MDGA, physician assessment of disease activity (100 mm); CRP, C-reactive protein (mg/l); ESR, erythrocyte sedimentation rate (mm/h); DAS28-ESR, disease activity score evaluating 28 joints; CDAI, clinical disease activity index; SDAI, simplified disease activity index; z, z-test for equality of two independent means (z > 0 if the mean for the Dutch population was higher than that of the Portuguese).